Give me a reason why they need to release Ph1b results.
They have the cash to complete Ph1b.
Voting for pay rise closing soon & major shareholders seem happy to give them.
They’re not in rush to attract big pharma.
If anything, by replacing the Ph1b end date with Ph2 end date in the website, they’re probably indicating that they won’t release Ph1b results. They have shown so far that satisfying shareholders aren’t top of their priorities at all, except when they need a CR.
I might be wrong of course, but so far the market sentiments agree with me. Maybe time to put this in bottom drawer for another year or two...
Clinical Trial Website Update, page-24
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 3.9¢ | 3.7¢ | $388.1K | 10.11M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 146314 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 2536521 | 6 |
View Market Depth
| Last trade - 16.10pm 02/12/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
